Associated Papers
TP53 mutation heterogeneity reveals distinct prognoses in mantle cell lymphoma.
Liu S et al.
Annals of Hematology, 2026
41559357 (PubMed )
Supplement: 277_2026_6771_MOESM2_ESM.xlsx › TableS3
Deep CRISPR mutagenesis characterizes the functional diversity of TP53 mutations.
Funk JS et al.
Nature Genetics, 2025
39774325 (PubMed )
Supplement: 41588_2024_2039_MOESM5_ESM.xlsx › SuppFig6
Comprehensive classification of TP53 somatic missense variants based on their impact on p53 structural stability.
Tam B et al.
Briefings in Bioinformatics, 2024
39140857 (PubMed )
Supplement: table_s1_bbae400.xlsx › Sheet1
Ultradeep sequencing differentiates patterns of skin clonal mutations associated with sun-exposure status and skin cancer burden.
Wei L et al.
Science Advances, 2021
33523857 (PubMed )
Supplement: abd7703_SM.pdf
Competitive evolution of NSCLC tumor clones and the drug resistance mechanism of first-generation EGFR-TKIs in Chinese NSCLC patients.
Deng Q et al.
Heliyon, 2018
30603682 (PubMed )
Supplement: mmc2.xlsx › Raw_reads_info
A peculiar mutation spectrum emerging from young peruvian patients with hepatocellular carcinoma.
Marchio A et al.
Plos One, 2014
25502816 (PubMed )
Supplement: pone.0114912.s003.xls › Feuil1
Mutation analysis of the SLX4/FANCP gene in hereditary breast cancer.
Landwehr R et al.
Breast Cancer Research and Treatment, 2011
Gene mutations and polymorphisms of TP53 and FHIT in chronic esophagitis and esophageal carcinoma.
Silveira AP et al.
Anticancer Research, 2011
Select a paper to view details